Zacks Research downgraded shares of Teleflex (NYSE:TFX – Free Report) from a strong-buy rating to a hold rating in a report published on Tuesday morning,Zacks.com reports. Wall Street Zen lowered Teleflex from a “strong-buy” rating to a “buy” rating in a research report on Monday, September 15th. Finally, Mizuho boosted their target price on Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research report on Friday, August 1st. Following the completion of the transaction, the director owned 7,192 shares in the company, valued at approximately $828,878. Teleflex Company Profile(Get Free Report)Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.